1.8(top 50%)
impact factor
236(top 50%)
papers
2.6K(top 50%)
citations
22(top 20%)
h-index
1.9(top 50%)
impact factor
340
all documents
2.9K
doc citations
42(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic SclerosisJournal of Scleroderma and Related Disorders2017321
2Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunitiesJournal of Scleroderma and Related Disorders2017243
3Gastrointestinal manifestations of systemic sclerosisJournal of Scleroderma and Related Disorders2016106
4Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and FibrosisJournal of Scleroderma and Related Disorders2017102
5Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomesJournal of Scleroderma and Related Disorders201673
6Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) DefinitionJournal of Scleroderma and Related Disorders201762
7The Mighty Fibroblast and Its Utility in Scleroderma ResearchJournal of Scleroderma and Related Disorders201757
8Pathogenesis of systemic sclerosis associated interstitial lung diseaseJournal of Scleroderma and Related Disorders202053
9The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinibJournal of Scleroderma and Related Disorders202051
10Treatment of systemic sclerosis–associated interstitial lung disease: Lessons from clinical trialsJournal of Scleroderma and Related Disorders202043
11Systemic sclerosis trial design moving forwardJournal of Scleroderma and Related Disorders201642
12Emerging strategies for treatment of systemic sclerosisJournal of Scleroderma and Related Disorders201641
13Update on morbidity and mortality in systemic sclerosis–related interstitial lung diseaseJournal of Scleroderma and Related Disorders202139
14Natural history of systemic sclerosis–related interstitial lung disease: How to identify a progressive fibrosing phenotypeJournal of Scleroderma and Related Disorders202034
15Patient-reported outcome instruments for assessing Raynaud’s phenomenon in systemic sclerosis: A SCTC vascular working group reportJournal of Scleroderma and Related Disorders201833
16Kidney involvement in systemic sclerosis: From pathogenesis to treatmentJournal of Scleroderma and Related Disorders201832
17Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung diseaseJournal of Scleroderma and Related Disorders201931
18The Critical Need for Accurately Defining Digital Ulcers in SclerodermaJournal of Scleroderma and Related Disorders201729
19Contribution of Interleukin-6 to the Pathogenesis of Systemic SclerosisJournal of Scleroderma and Related Disorders201727
20Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial designJournal of Scleroderma and Related Disorders201827
21Managing Systemic Sclerosis-Related Interstitial Lung Disease in the Modern Treatment EraJournal of Scleroderma and Related Disorders201726
22Digital Ulcers in Ssc Treated with Oral Treprostinil: A Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Follow-upJournal of Scleroderma and Related Disorders201725
23Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionJournal of Scleroderma and Related Disorders202225
24Systemic sclerosis-related calcinosisJournal of Scleroderma and Related Disorders201624
25Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesisJournal of Scleroderma and Related Disorders202024
26Antisynthetase syndrome: A distinct disease spectrumJournal of Scleroderma and Related Disorders202024
27Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patientsJournal of Scleroderma and Related Disorders201723
28Advances in nailfold capillaroscopic analysis in systemic sclerosisJournal of Scleroderma and Related Disorders201823
29Update on assessment and management of primary cardiac involvement in systemic sclerosisJournal of Scleroderma and Related Disorders201823
30Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosisJournal of Scleroderma and Related Disorders201822
31Mechanistic and clinical insights at the scleroderma-cancer interfaceJournal of Scleroderma and Related Disorders201721
32Musculoskeletal Involvement in Systemic Sclerosis: An Unexplored Aspect of the DiseaseJournal of Scleroderma and Related Disorders201721
33Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United StatesJournal of Scleroderma and Related Disorders201821
34Limited cutaneous systemic sclerosis: the unfairly neglected subsetJournal of Scleroderma and Related Disorders201620
35Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohortJournal of Scleroderma and Related Disorders201920
36Nailfold capillaroscopy in systemic sclerosis – state of the art: The evolving knowledge about capillaroscopic abnormalities in systemic sclerosisJournal of Scleroderma and Related Disorders201920
37The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancementJournal of Scleroderma and Related Disorders202120
38What have multicentre registries across the world taught us about the disease features of systemic sclerosis?Journal of Scleroderma and Related Disorders201718
39Raynaud’s phenomenonJournal of Scleroderma and Related Disorders201918
40Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An OverviewJournal of Scleroderma and Related Disorders201717
41Review of local wound management for scleroderma-associated digital ulcersJournal of Scleroderma and Related Disorders201817
42COVID-19 and systemic sclerosis: Rising to the challenge of a pandemicJournal of Scleroderma and Related Disorders202117
43Controversies: molecular vs. clinical systemic sclerosis classificationJournal of Scleroderma and Related Disorders201616
44Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysisJournal of Scleroderma and Related Disorders201815
45Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morpheaJournal of Scleroderma and Related Disorders201915
46Mycophenolate mofetil following cyclophosphamide in worsening systemic sclerosis-associated interstitial lung diseaseJournal of Scleroderma and Related Disorders201614
47Updates on animal models of systemic sclerosisJournal of Scleroderma and Related Disorders201614
48Clinical significance and usefulness of rehabilitation for systemic sclerosisJournal of Scleroderma and Related Disorders201814
49Circulating biomarkers of systemic sclerosis – interstitial lung diseaseJournal of Scleroderma and Related Disorders202014
50Patient-reported outcome instruments in clinical trials of systemic sclerosisJournal of Scleroderma and Related Disorders202014